Zai Lab Announces Pricing of Public Offering of American Depositary Shares

Author's Avatar
Sep 06, 2018
Article's Main Image

SHANGHAI, China, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced the pricing of its underwritten public offering of $150,000,000 of American Depositary Shares (“ADSs”) representing ordinary shares of the Company.